Sherry Weigand

Sr. Director at Takeda Pharmaceuticals (formerly Nycomed) - Lexington, MA, US

Sherry Weigand's Colleagues at Takeda Pharmaceuticals (formerly Nycomed)
Donald Blaha

Director, Managed Markets Account Strategy/Account Planning and Analytics

Contact Donald Blaha

Robert Baughman

Sr. Dir., Quantitative Clinical Pharmacology

Contact Robert Baughman

Amy Wang

Director Quality Control of Oncology and External Supply Small Molecule

Contact Amy Wang

Mike Skalitzky

Associate Director - Global Manufacturing Sciences - Package Engineering

Contact Mike Skalitzky

View All Sherry Weigand's Colleagues
Sherry Weigand's Contact Details
HQ
224-554-6500
Location
Company
Takeda Pharmaceuticals (formerly Nycomed)
Sherry Weigand's Company Details
Takeda Pharmaceuticals (formerly Nycomed) logo, Takeda Pharmaceuticals (formerly Nycomed) contact details

Takeda Pharmaceuticals (formerly Nycomed)

Lexington, MA, US • >10000 Employees
Major Drugs

On October 1, 2011, Takeda Pharmaceutical Company Limited acquired Nycomed. Through the acquisition, Takeda, the largest pharma company in Asia, broadened its coverage of the global pharmaceutical market, especialy in Europe and emergig markets. More information on http://www.takeda.com. The below information is from before the acquisition: Nycomed is a privately owned global pharmaceutical company with a diversified portfolio focused on branded medicines in gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. A range of OTC products completes the portfolio. Its R&D is structured around collaborations. In-licensing and expanding in emerging markets are cornerstones of the company's growth strategy. Nycomed employs 12,500 associates worldwide, and its products are sold in more than 100 countries. It has strong platforms in Europe and in fast-growing markets such as Russia/CIS, Latin America, Asia and the Middle East. In the US and Japan its products are available through best in class partners. Headquartered in Zurich, Switzerland, the company generated total sales of € 3.2 billion in 2010 and an adjusted EBITDA of € 851 million.

Branded Pharmaceuticals Gastroenterology Respiratory Conditions Inflammatory Diseases Pain Management Osteoporosis Treatment Over The Counter
Details about Takeda Pharmaceuticals (formerly Nycomed)
Frequently Asked Questions about Sherry Weigand
Sherry Weigand currently works for Takeda Pharmaceuticals (formerly Nycomed).
Sherry Weigand's role at Takeda Pharmaceuticals (formerly Nycomed) is Sr. Director.
Sherry Weigand's email address is ***@takeda.com. To view Sherry Weigand's full email address, please signup to ConnectPlex.
Sherry Weigand works in the Major Drugs industry.
Sherry Weigand's colleagues at Takeda Pharmaceuticals (formerly Nycomed) are Art Rice, Donald Blaha, Takeshi Seita, Robert Baughman, Atsushi Hasuoka, Amy Wang, Mike Skalitzky and others.
Sherry Weigand's phone number is 224-554-6500
See more information about Sherry Weigand